copper sulfate has been researched along with Parkinson Disease, Secondary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilera, P; Floriano-Sánchez, E; Monroy-Noyola, A; Montes, S; Pérez-Severiano, F; Ríos, C; Rubio, C; Rubio-Osornio, M | 1 |
1 other study(ies) available for copper sulfate and Parkinson Disease, Secondary
| Article | Year |
|---|---|
Copper reduces striatal protein nitration and tyrosine hydroxylase inactivation induced by MPP+ in rats.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Blotting, Western; Copper Sulfate; Dopamine; Dopamine Agents; Electrophoresis, Polyacrylamide Gel; Male; MPTP Poisoning; Neostriatum; Nerve Tissue Proteins; Nitrates; Nitric Oxide Synthase Type I; Parkinson Disease, Secondary; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 2009 |